Medicsight promotes Boyse to COO

TriMed Staff | | Health Imaging | Artificial Intelligence
Medicsight PLC last week announced the promotion of Adam Boyse, former product delivery director to the position of chief operating officer. Boyse now reports to Tim Paterson-Brown, Medicsight CEO. In his position, Boyse will drive operational activities in addition to the continued direction of the company's product development team and product pipeline.

Boyse joined Medicsight in May after nearly 15 years in the software development sector. Recently, he served as vice president of software development at IDBS, a market-leading life sciences software company, where he oversaw the growth of the development group and steered the company to ISO 9001 and TickIT certification.  
       
Since joining Medicsight, Boyse has assumed responsibilities for regulatory strategy and has led development of the company's new product pipeline, allowing the products to be integrated into 3D workstations and PACS.

TriMed Staff

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.